John Stellwagen

USPTO Granted Patents = 8 (Patent Applications = 10)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 26(Granted Patents)

Location History:

Durham, NC (US) (2013)
Beverly, MA (US) (2015 - 2023)

Company Filing History:

Teijin Pharma Limited

patents

Years Active: 2013-2023

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11807634 - Cyclopropyl dihydroquinoline sulfonamide compounds (2023-11-07),

2. 11332459 - Benzimidazole derivatives and their uses (2022-05-17),

3. 10472356 - Bicyclic ketone sulfonamide compounds (2019-11-12),

4. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use (2017-01-31),

5. 9309263 - Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof (2016-04-12),

6. 9115127 - Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase (2015-08-25),

7. 9096615 - Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof (2015-08-04),

8. 8415345 - Benzene sulfonamide thiazole and oxazole compounds (2013-04-09),

Title: John Stellwagen: Innovator in Pharmaceutical Chemistry

Introduction

John Stellwagen, an accomplished inventor based in Beverly, MA, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of seven patents, John has focused on developing innovative compounds that hold promise for therapeutic applications.

Latest Patents

Among his latest inventions are "Cyclopropyl dihydroquinoline sulfonamide compounds," which provide novel therapeutic options. Additionally, he has developed "Benzimidazole derivatives and their uses," pertaining to inhibitors of Transient Receptor Potential Channel 6 (TRPC6) protein activity. His inventions include compounds of Formula (I) and provide methods for their manufacturing along with pharmaceutical compositions, emphasizing their significant therapeutic potentials.

Career Highlights

John has built a strong career in the pharmaceutical industry, notably with Amgen Inc. and Teijin Pharma Limited. His work at these reputable companies has facilitated advancements in drug development, showcasing his expertise in translating scientific discoveries into real-world applications.

Collaborations

Throughout his career, John Stellwagen has collaborated with esteemed colleagues, including Angel Guzman-Perez and Zihao Hua. These collaborations have played a crucial role in enriching his research and enhancing the impact of his inventions in the pharmaceutical sector.

Conclusion

In conclusion, John Stellwagen stands out as a notable inventor, dedicated to advancing medical science through innovative pharmaceutical compounds. His work continues to influence the field, promising new therapeutic avenues for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.